Literature DB >> 34806425

The Year in Basic Thyroid Cancer Research.

Antonio Di Cristofano1.   

Abstract

Background: Every year, the American Thyroid Association (ATA) Annual Meeting opening session features presentations covering the most recent advances in the three major areas of thyroidology: basic, clinical, and surgical. As the ATA did not have an annual meeting in 2020, because of the COVID19 pandemic, the 2021 meeting opened with a special "Two Years in Thyroidology" session.
Methods: A PubMed electronic search was conducted to identify original basic science research studies on thyroid cancer published between October 2019 and September 2021. Methodologically rigorous studies that were deemed most likely to influence the field of basic science research in thyroid cancer were grouped into three thematic units: Genetics and Genomics, Molecular Biology and Signaling, and Preclinical and Translational Science. Four publications for each category were chosen for discussion.
Results: Selected studies covered topics ranging from the genetics of thyroid cancer predisposition to the genomics of anaplastic thyroid cancer evolution, from novel molecular pathways involved in thyroid cancer pathogenesis to potentially game-changing imaging and therapeutic innovations. Conclusions: The past two years, in the face of unique COVID19 pandemic-associated hurdles, have witnessed a large number of important developments in basic and translational thyroid cancer research. These studies not only have shed novel light on a number of long-standing scientific questions but have also highlighted the major challenges and open questions that still remain to be addressed in the coming years.

Entities:  

Keywords:  genetics; genomics; signaling; thyroid cancer; translational research

Mesh:

Year:  2021        PMID: 34806425      PMCID: PMC8792493          DOI: 10.1089/thy.2021.0561

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.506


  15 in total

1.  The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors.

Authors:  John J Liang; Zhengxin Wang; Luis Chiriboga; M Alba Greco; Ellen Shapiro; Hongying Huang; Ximing J Yang; Jiaoti Huang; Yi Peng; Jonathan Melamed; Michael J Garabedian; Peng Lee
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

2.  Altered differentiation and proliferation of prostate epithelium in mice lacking the androgen receptor cofactor p44/WDR77.

Authors:  Shen Gao; Hong Wu; Fen Wang; Zhengxin Wang
Journal:  Endocrinology       Date:  2010-06-02       Impact factor: 4.736

3.  An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.

Authors:  Julia Ramírez-Moya; Christos Miliotis; Allison R Baker; Richard I Gregory; Frank J Slack; Pilar Santisteban
Journal:  Mol Cancer       Date:  2021-09-08       Impact factor: 41.444

4.  SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies.

Authors:  Mahesh Saqcena; Luis Javier Leandro-Garcia; Jesper L V Maag; Vatche Tchekmedyian; Gnana P Krishnamoorthy; Prasanna P Tamarapu; Vera Tiedje; Vincent Reuter; Jeffrey A Knauf; Elisa de Stanchina; Bin Xu; Xiao-Hui Liao; Samuel Refetoff; Ronald Ghossein; Ping Chi; Alan L Ho; Richard P Koche; James A Fagin
Journal:  Cancer Discov       Date:  2020-12-14       Impact factor: 39.397

5.  Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness.

Authors:  Yea Eun Kang; Jin Man Kim; Mi Ae Lim; Seong Eun Lee; Shinae Yi; Jung Tae Kim; Chan Oh; Lihua Liu; Yanli Jin; Seung-Nam Jung; Ho-Ryun Won; Jae Won Chang; Jeong Ho Lee; Hyun Jung Kim; Hyun Yong Koh; Sangmi Jun; Sun Wook Cho; Minho Shong; Bon Seok Koo
Journal:  Thyroid       Date:  2021-01-07       Impact factor: 6.568

6.  Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident.

Authors:  Lindsay M Morton; Danielle M Karyadi; Chip Stewart; Tetiana I Bogdanova; Eric T Dawson; Mia K Steinberg; Jieqiong Dai; Stephen W Hartley; Sara J Schonfeld; Joshua N Sampson; Yosef E Maruvka; Vidushi Kapoor; Dale A Ramsden; Juan Carvajal-Garcia; Charles M Perou; Joel S Parker; Marko Krznaric; Meredith Yeager; Joseph F Boland; Amy Hutchinson; Belynda D Hicks; Casey L Dagnall; Julie M Gastier-Foster; Jay Bowen; Olivia Lee; Mitchell J Machiela; Elizabeth K Cahoon; Alina V Brenner; Kiyohiko Mabuchi; Vladimir Drozdovitch; Sergii Masiuk; Mykola Chepurny; Liudmyla Yu Zurnadzhy; Maureen Hatch; Amy Berrington de Gonzalez; Gerry A Thomas; Mykola D Tronko; Gad Getz; Stephen J Chanock
Journal:  Science       Date:  2021-04-22       Impact factor: 63.714

7.  Germ-line mutations in WDR77 predispose to familial papillary thyroid cancer.

Authors:  Yanyang Zhao; Tian Yu; Jie Sun; Feiliang Wang; Chaoze Cheng; Shurong He; Lan Chen; Donghui Xie; Liping Fu; Xuhuizi Guan; An Yan; Yao Li; Gang Miao; Xiaoquan Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

8.  Pre-existing Thyroiditis Ameliorates Papillary Thyroid Cancer: Insights From a New Mouse Model.

Authors:  Fabiana Pani; Yoshinori Yasuda; Giulia Di Dalmazi; Paulina Chalan; Kathleen Gabrielson; Luigi Adamo; Elena Sabini; Stefano Mariotti; Patrizio Caturegli
Journal:  Endocrinology       Date:  2021-10-01       Impact factor: 5.051

9.  ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.

Authors:  Julia Ramírez-Moya; Allison R Baker; Frank J Slack; Pilar Santisteban
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

10.  Characterizing dedifferentiation of thyroid cancer by integrated analysis.

Authors:  Han Luo; Xuyang Xia; Gyeong Dae Kim; Yang Liu; Zhinan Xue; Lingyun Zhang; Yang Shu; Tian Yang; Yan Chen; Shouyue Zhang; Haining Chen; Weihan Zhang; Ruicen Li; Huairong Tang; Birong Dong; Xianghui Fu; Wei Cheng; Wei Zhang; Li Yang; Yong Peng; Lunzhi Dai; Hongbo Hu; Yong Jiang; Changyang Gong; Yiguo Hu; Jingqiang Zhu; Zhihui Li; Carlos Caulin; Tao Wei; Jihwan Park; Heng Xu
Journal:  Sci Adv       Date:  2021-07-28       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.